RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer

Olav Engebraaten, Christina Yau, Kristian Berg, Elin Borgen, Øystein Garred, Maria E.B. Berstad, Ane S.V. Fremstedal, Angela De Michele, Laura van’t Veer, Laura Esserman, Anette Weyergang
doi: https://doi.org/10.1101/2021.07.06.21255069

Article usage

Article usage: July 2021 to March 2025

AbstractFullPdf
Jul 202112091266
Aug 20218281851
Sep 202167924
Oct 2021681625
Nov 202161136
Dec 20213765
Jan 20222362
Feb 20222644
Mar 20222962
Apr 20222483
May 20222009
Jun 20222598
Jul 20222134
Aug 20223116
Sep 20223347
Oct 20223113
Nov 20221876
Dec 20221553
Jan 202315138
Feb 20231646
Mar 20231044
Apr 20232225
May 20231343
Jun 20231172
Jul 20231051
Aug 202318215
Sep 20231562
Oct 20231063
Nov 2023221011
Dec 20231523
Jan 20241049
Feb 20241083
Mar 20241151
Apr 2024738
May 2024823
Jun 20241836
Jul 20241012
Aug 202412810
Sep 20241535
Oct 2024913
Nov 202411117
Dec 2024666
Jan 20251258
Feb 202561814
Mar 20258260
Back to top
Posted July 07, 2021.
Download PDF

Supplementary Material

Data/Code
Email
RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer
Olav Engebraaten, Christina Yau, Kristian Berg, Elin Borgen, Øystein Garred, Maria E.B. Berstad, Ane S.V. Fremstedal, Angela De Michele, Laura van’t Veer, Laura Esserman, Anette Weyergang
medRxiv 2021.07.06.21255069; doi: https://doi.org/10.1101/2021.07.06.21255069
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area